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Familial Creutzfeldt-Jakob Disease with V180I Mutation 
Creutzfeldt-Jakob disease (CJD) is an uncommon neurodegenerative disorder with an 
incidence of 1 per 1000,000 per year typically characterized by rapidly progressive 
dementia, ataxia, myoclonus and behavioral changes. Genetic prion diseases, which 
develop due to a mutations in the prion protein gene (PRNP), account for an 
estimated 10 to 15% of all CJD cases. We report a 75-yr-old woman with familial 
CJD carrying a V180I mutation which features late onset, slow progression, no 
periodic sharp wave complexes on electroencephalography, and extensive cortical 
ribboning with spared the cerebellum and the medial occipital lobes posterior to the 
parieto-occipital sulcus on MRI. To our knowledge, this is the first documented case 
of a point mutation at codon 180 in South Korea. 
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CASE REPORT
Neuroscience
INTRODUCTION
Creutzfeldt-Jakob diseases (CJD) is a rare neurodegenerative 
disorder with rapidly progressive dementia, cerebellar ataxia, 
myoclonus, and behavioral changes (1). Human prion diseases 
have an incidence of 1 or 2 cases per million population per 
year. Although most CJD cases are sporadic, genetic prion dis-
ease, including familial CJD (fCJD), due to mutations in the pri-
on protein gene (PRNP) account for only 10-15% of all CJD cas-
es (2). More than 55 mutations associated with genetic prion 
disease and more than 20 with fCJD have been identified (3, 4), 
and showed variations in clinical manifestations depending on 
each genotype. We report a 75-yr-old woman with a PRNP point 
mutation causing fCJD due to a substitution of an isoleucine for 
a valine at codon 180 (V180I). Analysis of associated studies sug-
gests this is the first reported case of fCJD with mutation V180I 
in South Korea.
CASE REPORT
A 75-yr-old right-handed woman presented with a 8 month his-
tory of neuropsychiatric symptoms and progressive dementia. 
Her family described that her symptoms started with severe de-
pression, including suicidal ideation. She became frequently ir-
ritable and would not go outside for fear of getting hit by a car. 
Further, she suffered from delusions of people on the television 
staring at her and visual hallucinations such as a thief writing 
letters on the wall with black paint. Antidepressants did not help 
her symptoms. 
  Approximately 4 months before her admittance to the hospi-
tal, she developed memory problems. She asked for the same 
items repeatedly. She did not remember who she was speaking 
with on the phone, making transitions in conversation as if she 
had suddenly spoken with a person other than the one she was 
actually speaking with. Her memory gradually worsened, which 
led to a diagnosis of dementia at a local psychiatric clinic. Within 
2 months, her cognitive decline and behavioral changes were 
more prominent. She had difficulty finding the bathroom at home 
and recognizing her family. Her behaviors were stereotypic and 
disinhibited, such as walking in and out of rooms repeatedly and 
walking around her house in the nude. She appeared to lack con-
trol over her emotions and she became more apathetic and less 
talkative. Additionally, her motivation diminished until she would 
only eat and bathe herself. 
  Four years prior to the onset of her symptoms, she underwent 
lumbar spine surgery. There was no family history of neurologi-Yang T-I, et al.  •  Familial CJD
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cal and psychiatric illness. She had six years of education and 
no history of alcohol or substance abuse. 
  Upon admittance, her general physical examination was un-
remarkable. The cranial nerve examination was normal. Her 
muscle tone was slightly increased bilaterally in the upper ex-
tremities. Bradykinesia and clumsiness in upper limbs were not–
ed. She had mild dysmetria with finger-to-nose test bilaterally. 
Her gait was slow but nearly normal based, with symmetrical 
arm swing. Knee jerks were present but diminished and she had 
a right extensor plantar response. 
  Laboratory studies including CBC, electrolytes, chemistry, lip-
id profiles, liver function, thyroid function, tumor markers, au-
toimmune laboratories and viral antibodies were within normal 
limits. Electrocardiography and chest radiography were also nor-
mal. 
  On neuropsychological testing, her Korean Mini-Mental State 
Examination (K-MMSE) score was 14/30. Overall, she showed 
severely impaired attention, language related functions (com-
prehension, naming, repetition, praxis, calculation), verbal and 
visual memory, visuospatial and frontal executive functions 
(Table 1). 
  Diffusion weighted and FLAIR axial brain MRIs demonstrated 
high signal intensities involving bilateral frontal, parietal, tem-
poral and occipital cortices, especially on the right hemisphere. 
High signal intensities were also seen in the right caudate nucle-
us and the putamen, but both cerebellum and medial regions 
posterior to parieto-occipital sulcus were spared (Fig. 1).
  Cerebrospinal fluid (CSF) examination showed no white blood 
cells, normal glucose and mildly elevated protein (74.2 mg/dL). 
An electroencephalography (EEG) on the fifth day of admission 
revealed intermittent 6-8 Hz of slow wave on right hemisphere. 
Her second EEG, taken on the eleventh admission date, showed 
1-2 Hz of continuous slow waves predominantly on bilateral 
frontal area. During admission, she had several obsessive-com-
pulsive behaviors such as washing her hands every 30 min and 
cleaning her genital area repeatedly. She wandered around the 
ward, however her cognitive and behavioral abnormalities did 
not change significantly throughout her admission. There were 
no significant differences on a follow-up brain MRI, conducted 
19 days after admission. On the twenty-second day, a third EEG 
showed 3-5 Hz of continuous slow waves predominantly in the 
right hemisphere. Thirty-seven days after admission, she was 
discharged with no apparent clinical degeneration or improve-
ment. After discharge, it was confirmed that the 14-3-3 protein 
Table 1. Results of neuropsychological test
Tests Results
Attention
   Digit span forward/backward
4/4
Language & related functions
   Spontaneous speech
   Comprehension 
   Repetition 
   K-BNT
   Reading/Writing
   Calculation 
   Finger naming/Body part identification
   Right-left orientation
   Ideomotor/buccofacial Praxis
FL 
BL 
13/15
4/15 (0.01%ile)
NL/NL
6/12
NL
NL
1/5, 4/5
Visuospatial functions
   Interlocking pentagon/Copy of Rey-CFT NL/10
Memory
   Seoul Verbal Learing Test-free recall (1st/2nd/3rd trial /20 min  
       delay recall/recognition score) 
   Rey-CFT copy/immediate recall/ 20 min delayed recall/ 
       recognition score
0/3/3/0/14
10/0/0/12
Frontal/executive function
   Contrasting program/ Go-no-go test
   Fist-edge-palm
   Alternating hand movement
   Luria loop
   Alternating square & triangle
   Word fluency: Category items (animal/supermarket)
   Word fluency: Letter (ㄱ/ㅇ/ㅅ)
   Stroop (word reading, color reading)
AB/AB
AB
AB
PSV
NL
1/0
0/0/0
14/112, 20/112
K-MMSE 14/30
CDR/GDS/KDSQ/S-IADL/Barthel ADL 3/6/28/44/10
GDS, CGA-NPI 19/30, 106/144
K-BNT, Korean version of Boston Naming Test; Rey-CFT, Rey Complex Figure Test; K- 
MMSE, Korean version of Mini-Mental State Examination; CDR, Clinical dementia rating; 
GDS, Global deterioration scale; KDSQ, Korean Dementia Screening Questionnaire; 
S-IADL, Seoul-Instrumental activities of daily living; Barthel ADL, Barthel activities of 
daily living; GDS, Geriatric depression scale; CGA-NPI, Caregiver-administered-Neuro–
psychiatric inventory; ND, Not done; NL, Normal; AB, Abnormal; BL, Borderline; FL, 
Fluent.
Fig. 1. Diffusion weighted (upper row) and FLAIR 
(lower row) axial brain MRIs show high signal 
intensity in diffuse cerebral cortex with dominant 
involvement of right hemisphere. Cerebellum and 
medial occipital lobes posterior to the parieto-
occipital sulcus indicated by arrows are spared. Yang T-I, et al.  •  Familial CJD 
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in CSF was positive and sequencing of PRNP revealed a V180I 
mutation with methionin homozygosity at codon 129 and glu-
tamate homozygosity at codon 219 (Fig. 2). Her family did not 
want a follow-up examination. At last contact with the family, 
she was still alive 18 months after onset. 
DISCUSSION
Our case with rapidly progressive dementia over 8 months su-
perimposed on mild parkinsonism and cerebellar ataxia met 
WHO possible sCJD criteria at the time of presentation (5). Fur-
thermore, extensive abnormal high signal intensities involving 
cerebral cortices on both diffusion weighted brain MRIs and 
FLAIR images strongly suggested sCJD (6, 7). Although an EEG 
with periodic sharp and wave complexes (PSWC) is present in 
only about 60% of sCJD cases (8, 9) and not necessary for diagno–
sing probable sCJD by either WHO or UCSF criteria (10), which 
allow the use of 14-3-3 or MRI, respectively, our patient’s non-
diagnostic EEG and lack of progression during her admission 
led us to consider an alternative diagnosis such as a genetic pri-
on disease. 
  More than 55 different PRNP mutations have been associat-
ed with genetic prion diseases, including fCJD, and the clinical 
phenotype varies depending on the underlying mutation (3). 
Worldwide, the most common mutation is E200K (glutamate to 
lysine), the phenotype of which often is indistinguishable from 
that of sCJD (4).
  fCJD due to the V180I, as our patient’s, is extremely rare, with 
all reported cases have come from Japan with one from France 
(11, 12), and two in the United states in a non-Asian (Geschwind 
et al. unpublished results) (13). To our knowledge this is the first 
reported case in South Korea. 
  Jin et al. described characteristic clinical features of the fCJD 
associated with V180I as follows: 1) late onset, 2) slow progres-
sion, 3) frequent higher cortical dysfunction, 4) low positive rate 
of 14-3-3 protein, and 5) no PWSC on EEG (14). In addition, Jin 
noted that the MRI in fCJD with V180I showed extensive corti-
cal ribboning and sparing of the cerebellum and the medial oc-
cipital lobes posterior to the parieto-occipital sulcus on DWI se-
quences in the early stage of the disease (14). 
  Possibly due to the late age of onset and imcomplete pene-
trance, patients with genetic prion diaease often have no family 
history of dementia. The age of onset of our case was 74, which 
is slightly older than the mean age of onset for sCJD. This might 
be the cause of negative family history of dementia for our case.
  Our patient showed relatively slow progression during 37 day 
admission period, even still alive 18 months after onset, cortical 
dysfunction on neuropsychological test, and no PSWC on re-
peated EEGs. Her MRIs were compatible with those of previous 
reports about fCJD with V180I. Therefore, her clinical features, 
despite positive 14-3-3 protein, generally correspond with those 
of the previous reported cases with fCJD with V180I (14). 
  There have been several studies to investigate the influence of 
the polymorphism of codon 129 to clinical characteristics and 
neuropatholgic patterns in sCJD, iatrogenic CJD and variant CJD 
(15). However, the contribution of codon 129 polymorphism to 
V180I has not been established. Furthermore, there is no report 
about V180I with the polymorphism at codon 219.
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Fig. 2. (A) DNA sequence at codon 180 
of PRNP gene from the patient (left) and 
a control (right). The Letter “N” indicates 
a point mutation causing a substitution 
of GTC (Val) by ATC (Ile) at codon 180. 
Sequence in a control is homozygous for 
GTC (Val) at codon 180. (B) Homozygosity 
for methionine at codon 129 and (C) 
homozygosity for glutamate at codon 219 
are also identified in the sequence ana–
lysis of PRNP gene mutation of the pa–
tient.  Yang T-I, et al.  •  Familial CJD
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  This case may have clinical implications. That is, fCJD with 
V180I should be considered in all patients with late onset rap-
idly progressive dementia who showed rather atypical manifes-
tations with characteristic MRI features than those of sCJD de-
spite a negative family history.
REFERENCES 
1. Rabinovici GD, Wang PN, Levin J, Cook L, Pravdin M, Davis J, DeArmond 
SJ, Barbaro NM, Martindale J, Miller BL, Geschwind MD. First symptom 
in sporadic Creutzfeldt-Jakob disease. Neurology 2006; 66: 286-7.
2. Heinemann U, Krasnianski A, Meissner B, Grasbon-Frodl EM, Kretzs–
chmar HA, Zerr I. Novel PRNP mutation in a patient with a slow pro-
gressive dementia syndrome. Med Sci Monit 2008; 14: CS41-3. 
3. Kong QK, Surewicz WK, Petersen RB, Zhou W, Chen SG, Gambetti P, 
Parchi P, Capellari S, Goldfarb L, Montagna P, Lugaresi E, Piccardo P, 
Ghetti B. Inherited Prion Diseases. In Prusiner SB, ed. Prion Biology and 
Disease. 2nd ed. Cold Spring Harbor: Cold Spring Harbor Laboratory 
Press 2004; 673-776. 
4. Zerr I, Poser S. Clinical diagnosis and differential diagnosis of CJD and 
vCJD. With special emphasis on laboratory tests. APMIS 2002;110:88-98. 
5. WHO Global surveillance, diagnosis and therapy of human transmissi-
ble spongiform encephalopathies: Report of a WHO consultation. In 
World Health Organization, Emerging and other communicable diseas-
es, surveillance and control. Geneva: WHO 1998; February 9–11.
6. Shiga Y, Miyazawa K, Sato S, Fukushima R, Shibuya S, Sato Y, Konno H, 
Doh-ura K, Mugikura S, Tamura H, Higano S, Takahashi S, Itoyama Y. 
Diffusion-weighted MRI abnormalities as an early diagnostic marker for 
Creutzfeldt-Jakob disease. Neurology 2004; 63: 443-9. 
7. Young GS, Geschwind MD, Fischbein NJ, Martindale JL, Henry RG, Liu S, 
Lu Y, Wong S, Liu H, Miller BL, Dillon WP. Diffusion-weighted and fluid-
attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high 
sensitivity and specificity for diagnosis. AJNR Am J Neuroradiol 2005; 26: 
1551–62.
8. Collins SJ, Sanchez-Juan P, Masters CL, Klug GM, van Duijn C, Poleggi 
A, Pocchiari M, Almonti S, Cuadrado-Corrales N, de Pedro-Cuesta J, 
Budka H, Gelpi E, Glatzel M, Tolnay M, Hewer E, Zerr I, Heinemann U, 
Kretszchmar HA, Jansen GH, Olsen E, Mitrova E, Alpérovitch A, Brandel 
JP, Mackenzie J, Murray K, Will RG. Determinants of diagnostic investi-
gation sensitivities across the clinical spectrum of sporadic Creutzfeldt-
Jakob disease. Brain 2006; 129: 2278-87.
9. Steinhoff BJ, Zerr I, Glatting M, Schulz-Schaeffer W, Poser S, Kretzschmar 
HA. Diagnostic value of periodic complexes in Creutzfeldt-Jakob disease. 
Ann Neurol 2004; 56: 702-8.
10. Geschwind MD, Josephs KA, Parisi JE, Keegan BM. A 54-year-old man 
with slowness of movement and confusion. Neurology 2007; 69: 1881-7. 
11. Yamada M. Prion diseases in Japan: analysis of 918 patients. Rinsho Shin–
keigaku 2007; 47: 805-8.
12. Chasseigneaux S, Haik S, Laffont-Proust I, De Marco O, Lenne M, Bran-
del JP, Hauw JJ, Laplanche JL, Peoc’h K. V180I mutation of the prion pro-
tein gene associated with atypical PrPSc glycosylation. Neurosci Lett 2006; 
408: 165-9.
13. Nixon R, Camicioli R, Jamison K, Cervenakova L, Mastrianni JA. The 
PRNP-V180I mutation is associated with abnormally glycosylated PrP-
CJD and Intracellular PrP accumulations. Presented at XIVth Interna-
tional Congress of Neuropathology Scientific Programme. Brain Pathol-
ogy 2000; 10: 670.
14. Jin K, Shiga Y, Shibuya S, Chida K, Sato Y, Konno H, Doh-ura K, Kitamo-
to T, Itoyama Y. Clinical features of Creutzfeldt-Jakob disease with V180I 
mutation. Neurology 2004; 62: 502-5.
15. Alperovitch A, Zerr I, Pocchiari M, Mitrova E, de Pedro Cuesta J, Hegyi I, 
Collins S, Kretzschmar H, van Duijn C, Will RG. Codon 129 prion pro-
tein genotype and sporadic Creutzfeldt-Jakob disease. Lancet 1999; 353: 
1673-4.